Oleothorax: A Forgotten Complication of Historical Tuberculosis Treatment — Radiographic Findings, CT Diagnosis, Long-Term Complications, and Clinical Management
Abstract
Oleothorax is a rare, historically important pleural condition resulting from the deliberate introduction of oil into the pleural cavity as a form of collapse therapy for pulmonary tuberculosis (TB). Before effective antituberculous chemotherapy became available, physicians employed several invasive procedures to reduce pulmonary expansion, promote cavity closure, and theoretically limit the progression of tuberculosis. Oleothorax was one such intervention, involving the instillation of mineral or vegetable oil into the pleural space to maintain compression of the affected lung.
Although this treatment was largely abandoned following the introduction of effective antituberculous medications, residual intrapleural oil collections may persist for decades. These collections can become encapsulated, develop extensive peripheral calcification, and occasionally enlarge or produce clinically significant complications. Consequently, oleothorax may be discovered incidentally during chest radiography or computed tomography (CT) performed for unrelated symptoms, particularly in elderly patients with a remote history of pulmonary tuberculosis.
This article reviews the pathophysiology, historical background, epidemiology, clinical presentation, radiographic and CT findings, differential diagnosis, diagnostic approach, treatment, and prognosis of oleothorax. Two elderly patients with remote tuberculosis histories illustrate the importance of recognizing this unusual imaging finding. Particular attention is given to distinguishing oleothorax from calcified pleural empyema, chronic hemothorax, pleural tumors, and other thoracic masses.
Understanding oleothorax is important for contemporary radiologists, pulmonologists, thoracic surgeons, and clinicians because an apparently malignant thoracic mass may actually represent a benign residual of an obsolete tuberculosis treatment. Nevertheless, recognition of this historical condition should not lead to complacency, because delayed complications, including infection, fistula formation, progressive enlargement, and tuberculosis reactivation, have been documented.
Keywords: Oleothorax, pulmonary tuberculosis, collapse therapy, artificial pneumothorax, pleural disease, calcified pleural mass, chest radiography, chest CT, pleural calcification, chronic pleural collection, tuberculosis complications, thoracic imaging, radiology case report.
1. Introduction
Oleothorax is an uncommon but distinctive manifestation of historical tuberculosis treatment. It refers to the persistent presence of oil within the pleural cavity following therapeutic instillation of an oily substance to induce or maintain collapse of an affected lung.
Although unfamiliar to many contemporary clinicians, oleothorax represents an important chapter in the history of pulmonary medicine and thoracic imaging. Its recognition is particularly relevant when evaluating elderly individuals who present with an unexplained unilateral thoracic opacity, a calcified pleural mass, or an unusual apical lesion.
Before effective antituberculous medications became available, pulmonary tuberculosis was associated with substantial morbidity and mortality. Physicians explored several approaches intended to reduce pulmonary movement and promote healing of tuberculous cavities. These approaches collectively became known as collapse therapy.
Artificial pneumothorax, thoracoplasty, phrenic nerve interruption, extrapleural pneumolysis, and plombage were among the historical interventions used to manage selected patients with pulmonary tuberculosis.
Oleothorax was another technique within this therapeutic tradition. By introducing mineral oil or vegetable oil into the pleural space, clinicians attempted to produce sustained mechanical compression of the diseased lung.
The development of effective antituberculous medications transformed tuberculosis management and progressively eliminated the need for these invasive procedures. Streptomycin became an important milestone in 1944, followed by the introduction of isoniazid in 1952 and subsequent multidrug regimens.
Nevertheless, some patients retained their intrapleural oil collections because the planned aspiration was never performed or because long-term follow-up was interrupted.
Today, these residual collections may be discovered 50–80 years after the original intervention.
The most important clinical lesson is straightforward: a large, well-defined, calcified thoracic mass in an elderly patient with a remote history of tuberculosis should prompt consideration of oleothorax before an invasive diagnostic procedure is undertaken.
However, the presence of a suspected oleothorax does not automatically exclude malignancy, infection, or recurrent tuberculosis. A systematic imaging and clinical evaluation remains essential.
2. Historical Background: The Evolution of Collapse Therapy
2.1 Tuberculosis before effective chemotherapy
Pulmonary tuberculosis was a major cause of death during the nineteenth and early twentieth centuries. Before effective antimicrobial therapy, treatment options were limited, and physicians frequently relied on prolonged hospitalization, nutritional support, rest, and surgical interventions.
The discovery of Mycobacterium tuberculosis by Robert Koch in 1882 established the bacterial cause of the disease. Nevertheless, identifying the organism did not immediately provide an effective means of eliminating it.
One therapeutic concept was that reducing movement and ventilation of the affected lung might encourage healing of cavitary lesions.
This concept led to the development of pulmonary collapse therapy.
2.2 Artificial pneumothorax
Artificial pneumothorax involved introducing air into the pleural cavity to collapse the affected lung partially.
The technique was associated with Carlo Forlanini, who developed its clinical application in the late nineteenth century.
The objective was to reduce the mechanical stress on diseased lung tissue and promote closure of tuberculous cavities.
Although this approach could be useful in selected patients, maintaining a stable artificial pneumothorax was sometimes difficult because pleural air could be rapidly absorbed.
2.3 Development of oleothorax
Oleothorax emerged as another method of achieving sustained pulmonary collapse.
The technique involved introducing an oily substance, such as mineral oil, liquid paraffin, or vegetable oil, into the pleural cavity.
The oil occupied pleural space and exerted mechanical pressure on the adjacent lung.
Compared with air, oil was less readily absorbed, allowing the intended compressive effect to persist for an extended period.
Historical techniques varied, and the terms oleothorax, extrapleural pneumolysis, and plombage should not be considered interchangeable in every clinical context.
Oleothorax specifically refers to an oil-containing pleural collection. Plombage more broadly describes the creation of an extrapleural space filled with an implanted material, which could include oil, paraffin, or other substances.
This distinction is important when interpreting historical operative records and contemporary imaging.
2.4 Why was oleothorax abandoned?
The introduction of effective antituberculous chemotherapy fundamentally changed the management of pulmonary tuberculosis.
Streptomycin was identified as an effective antituberculous agent in 1944. The development of combination therapy subsequently improved treatment outcomes and reduced the need for invasive collapse procedures.
By the 1950s, oleothorax had largely disappeared from routine clinical practice.
The treatment was not simply discontinued because it was old-fashioned. It also carried important risks, including persistent foreign-material collections, infection, fistula formation, respiratory impairment, and delayed enlargement of the treated space.
Consequently, the historical intervention has become an important diagnostic consideration rather than an accepted contemporary treatment.
3. Pathophysiology of Oleothorax
3.1 Formation of an intrapleural oil collection
Under normal physiological conditions, the pleural cavity contains only a small amount of lubricating fluid between the visceral and parietal pleura.
In oleothorax, a relatively large quantity of oil is deliberately introduced into this space.
Historical procedures used varying volumes depending on the clinical indication and technique. Published reports describe volumes ranging from approximately 100 mL to as much as 2,000 mL.
The introduced oil produces mechanical compression of the adjacent lung and may contribute to pleural inflammation and fibrosis.
3.2 Mechanical compression and pulmonary collapse
The primary therapeutic mechanism was mechanical rather than antimicrobial.
By compressing the affected lung, oleothorax attempted to reduce pulmonary expansion and promote collapse of tuberculous cavities.
The theoretical objective was to create an unfavorable environment for mycobacterial persistence through reduced ventilation and mechanical restriction.
It is important to emphasize that oleothorax did not eradicate Mycobacterium tuberculosis and was never equivalent to effective antituberculous chemotherapy.
3.3 Chronic pleural encapsulation
When the oil remains in the pleural cavity, the surrounding pleural surfaces may develop chronic inflammatory and fibrotic changes.
Over time, a thick capsule may form around the collection.
The capsule can undergo dystrophic calcification, producing a characteristic calcified peripheral contour on chest radiographs and CT.
The resulting lesion may resemble a large calcified tumor or chronic organized pleural collection.
3.4 Delayed enlargement
One of the clinically important complications is progressive enlargement of a previously stable oleothorax.
Hutton described expanding oleothoraces that developed respiratory symptoms after remaining relatively stable for many years.
Proposed mechanisms include chronic pleural fluid production stimulated by the oil and persistent inflammatory changes within the pleural cavity.
An enlarging collection can compress adjacent lung tissue, reduce lung volume, and cause restrictive ventilatory impairment.
3.5 Secondary infection and tuberculosis reactivation
Persistent oil collections may become complicated by infection.
Reported complications include:
Chronic tuberculous empyema.
Secondary bacterial infection.
Bronchopleural fistula.
Pleurocutaneous fistula.
Chest wall abscess.
Airway compression or obstruction.
Progressive respiratory impairment.
Late tuberculosis reactivation.
Fahy and colleagues reported tuberculosis reactivation within an oleothorax 54 years after the original oil instillation.
This observation demonstrates why a remote history of collapse therapy should remain clinically relevant even when the original pulmonary tuberculosis appears to have resolved.
4. Epidemiology
4.1 Historical distribution
Oleothorax was used primarily during the pre-antibiotic era, particularly during the early and middle decades of the twentieth century.
Its historical use was associated with the prevalence of pulmonary tuberculosis and the availability of thoracic surgical interventions.
As effective antituberculous chemotherapy became widely available, the procedure was progressively abandoned.
4.2 Contemporary epidemiology
There are no reliable contemporary population-based estimates of the prevalence or incidence of oleothorax.
The condition is now encountered mainly through isolated case reports and retrospective recognition of old thoracic procedures.
Its apparent rarity reflects the historical nature of the intervention rather than evidence that the original procedure was uncommon in the populations in which it was performed.
Patients most likely to present with residual oleothorax include:
Older adults who received tuberculosis treatment before the widespread availability of effective chemotherapy.
Individuals with an undocumented history of collapse therapy.
Patients whose original treatment records are unavailable.
Individuals who were lost to follow-up before planned oil removal.
Patients undergoing chest imaging for unrelated conditions.
4.3 Why should contemporary radiologists recognize it?
The number of surviving individuals who underwent these procedures is decreasing.
However, patients with historical oleothorax may continue to present in modern clinical practice, particularly in regions where tuberculosis was historically prevalent.
The radiologist may be the first clinician to recognize this historical diagnosis.
Failure to identify oleothorax can result in unnecessary additional investigations, invasive biopsy, or even inappropriate surgical planning.
5. Clinical Presentation
5.1 Incidental discovery
Many patients with residual oleothorax remain asymptomatic for decades.
The condition may be discovered incidentally during chest radiography performed for:
Chest pain.
Abdominal pain.
Preoperative evaluation.
Cardiovascular assessment.
Suspected respiratory infection.
Routine health examinations.
Evaluation of unrelated pulmonary disease.
An asymptomatic presentation does not exclude a substantial residual pleural collection.
5.2 Respiratory symptoms
When symptoms develop, they may include:
Dyspnea.
Persistent cough.
Chest discomfort.
Pleuritic chest pain.
Reduced exercise tolerance.
Recurrent respiratory infections.
Symptoms may result from mechanical compression of adjacent lung tissue, chronic pleural inflammation, or secondary infection.
5.3 Symptoms associated with complications
Patients with complicated oleothorax may present with:
Fever.
Productive cough.
Hemoptysis.
Increasing chest pain.
Progressive breathlessness.
Weight loss.
Chest wall swelling.
Cutaneous drainage from a fistula.
These findings should prompt evaluation for infection, empyema, tuberculosis reactivation, or malignancy.
5.4 Physical examination
Physical findings depend on the size and location of the collection.
Possible findings include:
Reduced breath sounds over the affected hemithorax.
Dullness to percussion.
Reduced chest expansion.
Signs of chronic respiratory impairment.
Chest wall deformity or surgical scars.
A remote thoracic surgical scar can provide an important historical clue.
6. Imaging Features of Oleothorax
Imaging plays a central role in recognizing oleothorax and distinguishing it from malignant or infectious thoracic lesions.
6.1 Chest radiography
Chest radiography is frequently the first examination to identify residual oleothorax.
Typical findings include:
A well-defined unilateral pleural-based opacity.
An oval, rounded, or lenticular configuration.
Predominantly apical or upper thoracic location in many historical cases.
Peripheral or circumferential calcification.
Associated pleural thickening.
Compression or displacement of adjacent pulmonary parenchyma.
Evidence of previous thoracic surgery or tuberculosis-related pleural disease.
The lesion may appear as a large, sharply marginated calcified mass.
The presence of a characteristic pleural-based configuration and a compatible tuberculosis history should raise suspicion for oleothorax.
6.2 Interpretation of Figure 1: Initial case
Figure 1. Chest posteroanterior radiograph demonstrating a large, well-defined left upper thoracic opacity compatible with residual oleothorax. The lesion occupies the left apical and upper hemithoracic region and produces a mass-like appearance. In the clinical context of remote pulmonary tuberculosis treatment during the 1950s, the appearance strongly suggests a persistent historical intrapleural oil collection.
Radiologic teaching point: A large unilateral thoracic opacity in an elderly patient is not necessarily a primary lung neoplasm. Historical tuberculosis treatment, pleural calcification, and a characteristic pleural-based configuration should be considered.
6.3 Interpretation of Figure 2: Calcified oleothorax on PA radiography
Figure 2. Posteroanterior chest radiograph demonstrating a large, oval-shaped, peripherally calcified lesion in the left apical hemithorax (arrow), consistent with chronic oleothorax. A separate linear calcified pleural plaque along the right lateral thoracic wall (arrowhead) is compatible with previous tuberculous pleural inflammation. The sharply defined peripheral calcification and historical tuberculosis background support the diagnosis of residual oleothorax.
The radiograph demonstrates two distinct abnormalities:
The large left apical calcified mass, representing the suspected oleothorax.
The separate right-sided linear pleural calcification, consistent with a remote pleural inflammatory process.
These findings should not be interpreted as a single continuous lesion.
This distinction matters because pleural plaques and calcified pleural collections have different morphologic patterns and clinical implications.
6.4 Interpretation of Figure 3: Lateral chest radiography
Figure 3. Lateral chest radiograph demonstrating the large, well-circumscribed left upper thoracic opacity (arrow), compatible with a chronic calcified oleothorax. The lateral projection provides additional localization of the lesion within the upper thoracic pleural compartment and demonstrates its mass-like configuration.
The lateral projection is useful because it provides an additional spatial perspective.
A lesion that appears to overlap the pulmonary apex on the frontal projection may be more clearly localized to the pleural compartment on the lateral image.
Nevertheless, chest radiography alone may not always establish the exact anatomic relationship between the collection, pleura, chest wall, and adjacent lung.
Consider cross-sectional imaging when the diagnosis is uncertain, or complications are suspected.
6.5 Computed tomography
CT is particularly valuable for evaluating suspected oleothorax.
It provides detailed information regarding:
The precise location of the collection.
Pleural and extrapleural involvement.
The internal composition of the lesion.
Peripheral calcification.
Adjacent lung compression.
Chest wall involvement.
Associated air or fluid.
Possible infection or malignancy.
A characteristic CT appearance is an encapsulated collection with heterogeneous internal attenuation.
Published descriptions include a multilayered appearance consisting of:
A superior air-containing component.
An intermediate component with negative attenuation consistent with lipid material.
A dependent component with higher attenuation.
Reported attenuation values for lipid-containing components are approximately −30 to −150 Hounsfield units, although actual measurements depend on the material, degree of chronic organization, and technical factors.
The presence of negative attenuation within a well-defined pleural collection is an important clue.
However, not every oleothorax demonstrates all three components.
Chronic collections may become extensively organized, heterogeneous, or calcified.
Important limitation: The supplied three figures are chest radiographs. They do not include CT images of the two patients. The CT findings described here are based on published radiologic literature and should not be interpreted as findings directly demonstrated in the supplied images.
6.6 Magnetic resonance imaging
MRI is not routinely required to diagnose uncomplicated oleothorax.
However, it can be helpful when complications involve the chest wall, vertebral bodies, spinal canal, or adjacent soft tissues.
Fat-sensitive sequences may help identify lipid-containing material.
MRI can also assist in evaluating unusual osseous complications, including fatty infiltration of adjacent structures and pathologic vertebral fractures.
6.7 Ultrasonography
Recent literature has demonstrated that thoracic ultrasound can provide additional information in selected patients.
A 2024 report described characteristic sonographic findings, including:
Particular internal echogenicity.
A relatively rigid and static collection.
Peripheral calcifications.
Impaired diaphragmatic mobility and excursion.
Ultrasound may therefore be useful when a basal oleothorax affects diaphragmatic mechanics.
It should be considered a complementary modality rather than a replacement for CT when comprehensive thoracic characterization is required.
7. Differential Diagnosis
A calcified pleural or thoracic mass in an elderly patient has a broad differential diagnosis.
The most important diagnostic challenge is distinguishing oleothorax from chronic inflammatory, hemorrhagic, and neoplastic conditions.
7.1 Calcified pleural empyema
Chronic empyema may produce a thick-walled pleural collection with extensive calcification.
Associated findings may include:
Pleural thickening.
Residual pleural fluid.
Gas within the collection.
Adjacent pulmonary fibrosis.
Evidence of previous infection.
The clinical history and CT morphology are important for differentiation.
A history of historical oil instillation strongly supports oleothorax.
7.2 Chronic hemothorax
Chronic retained hemothorax may become organized and develop pleural thickening or calcification.
The diagnosis is supported by a history of trauma, surgery, anticoagulation-related bleeding, or previous pleural hemorrhage.
Unlike oleothorax, chronic hemothorax does not contain a characteristic lipid-rich component.
7.3 Pleural malignancy
Pleural malignancies, including malignant mesothelioma and metastatic pleural tumors, can produce mass-like pleural abnormalities.
Suspicious features include:
Nodular pleural thickening.
Circumferential pleural involvement.
Mediastinal pleural involvement.
Chest wall invasion.
Progressive enlargement.
Associated pleural effusion.
A history of asbestos exposure may increase concern for malignant mesothelioma.
Importantly, the identification of an old oleothorax does not automatically exclude an unrelated malignancy.
7.4 Primary lung cancer
A peripheral pulmonary tumor may mimic a pleural mass, especially when large.
Features favoring a pulmonary origin include:
A demonstrable parenchymal epicenter.
Spiculated margins.
Bronchovascular distortion.
Associated lymphadenopathy.
Direct invasion of surrounding structures.
CT is essential when the lesion's origin is unclear.
7.5 Calcified pleural plaques
Pleural plaques are localized areas of pleural fibrosis and calcification.
They are frequently associated with asbestos exposure but may also occur after previous pleural inflammation.
They typically appear as separate, localized pleural calcifications rather than a large encapsulated lipid-containing mass.
The right lateral pleural calcification in Figure 2 is an example of a separate pleural abnormality and should not be confused with the left-sided oleothorax.
7.6 Other differential diagnoses
Additional possibilities include:
Calcified tuberculous pleural collections.
Chronic organized pleural hematoma.
Extrapleural plombage materials.
Calcified mediastinal lesions.
Chronic hydatid disease.
Chest wall tumors.
Benign pleural tumors.
The diagnostic approach should integrate clinical history, lesion location, morphology, CT attenuation, and interval imaging.
8. Diagnosis and Diagnostic Approach
The diagnosis of oleothorax is primarily based on clinical history and imaging findings.
Step 1: Obtain a detailed medical history
The clinician should ask about:
Previous pulmonary tuberculosis.
Treatment received during the 1930s–1950s.
Previous artificial pneumothorax.
Thoracic surgery.
Historical collapse therapy.
Previous pleural procedures.
Longstanding unilateral chest abnormalities.
Patients may not remember the details of procedures performed many decades earlier.
Family members and archived medical records may provide useful information.
Step 2: Review chest radiographs
Identify:
The lesion's location.
Its shape and margins.
The presence of peripheral calcification.
Associated pleural abnormalities.
Signs of previous thoracic surgery.
Changes compared with previous imaging.
Step 3: Perform chest CT when indicated
CT is recommended when:
The diagnosis is uncertain.
The lesion appears to be enlarging.
There is concern for malignancy.
Secondary infection is suspected.
The patient has unexplained respiratory symptoms.
Chest wall or mediastinal involvement must be assessed.
Step 4: Consider microbiological evaluation
When infection or tuberculosis reactivation is suspected, appropriate testing may include:
Sputum acid-fast bacillus smear.
Mycobacterial culture.
Molecular testing for Mycobacterium tuberculosis.
Additional microbiological studies based on clinical findings.
Step 5: Consider aspiration or biopsy selectively
Pleural aspiration may be useful when the diagnosis remains uncertain or infection is suspected.
Historical reports describe the recovery of viscous mineral oil from the pleural collection.
However, aspiration should not be performed automatically for every characteristic, asymptomatic oleothorax.
The procedure carries potential risks, including infection and injury to adjacent structures.
Biopsy is generally reserved for cases in which imaging demonstrates suspicious features that cannot be adequately explained by the historical treatment.
9. Treatment and Management
Management depends on the patient's symptoms, lesion stability, and the presence or absence of complications.
There is no justification for automatically removing every residual oleothorax.
9.1 Conservative management
Observation is appropriate for selected patients who have:
No significant respiratory symptoms.
Stable imaging findings.
No evidence of active infection.
No suspicious malignant features.
No clinically important compression of adjacent structures.
Clinical assessment and comparison with previous imaging are important.
The frequency of follow-up should be individualized according to symptoms, lesion characteristics, and overall clinical condition.
9.2 Drainage and aspiration
Drainage may be considered when a collection causes significant symptoms or when infection requires source control.
The decision should be made by an experienced pleural or thoracic specialist.
Longstanding pleurodesis may contain highly viscous material and may be surrounded by thick fibrotic capsules.
Consequently, simple aspiration may not provide adequate drainage.
9.3 Antibiotic therapy
Antibiotics are indicated when there is evidence of secondary bacterial infection.
Treatment should be guided by clinical findings, microbiological results, and local antimicrobial recommendations.
Antibiotics are not indicated merely because an asymptomatic chronic oleothorax is present.
9.4 Management of tuberculosis reactivation
When active tuberculosis is identified, contemporary multidrug antituberculous treatment should be initiated according to current national and international guidelines.
Management should involve pulmonary and infectious disease specialists.
The presence of a historical oleothorax does not change the fundamental need to diagnose and appropriately treat active tuberculosis.
9.5 Surgical management
Surgical intervention may be necessary in selected complicated cases.
Potential indications include:
Progressive enlargement with respiratory compromise.
Persistent or recurrent infection.
Bronchopleural fistula.
Pleurocutaneous fistula.
Chest wall complications.
Failure of less invasive management.
Strong suspicion of malignancy.
Depending on the clinical situation, treatment may involve drainage, decortication, removal of the residual collection, or more extensive thoracic surgery.
Surgery can be technically challenging because of dense pleural adhesions, chronic inflammation, and calcification.
The risks and expected benefits must be carefully assessed, particularly in elderly patients.
9.6 Management of the asymptomatic elderly patient
The two supplied cases illustrate an important clinical principle.
A large radiographic lesion does not necessarily require immediate invasive treatment.
When the clinical history and imaging are strongly compatible with a stable oleothorax, and there is no evidence of complications, conservative management may be appropriate.
The objective is to avoid unnecessary intervention while maintaining vigilance for delayed complications.
10. Prognosis and Long-Term Complications
The prognosis of oleothorax is variable and depends primarily on the stability of the collection and the presence of complications.
10.1 Favorable prognosis
Patients with a stable, uncomplicated oleothorax may remain asymptomatic for decades.
In such individuals, the lesion may represent an incidental radiographic finding rather than an active clinical problem.
10.2 Progressive enlargement
Some oleothoraces may enlarge after years of apparent stability.
Progressive enlargement can produce:
Compression of adjacent lung tissue.
Reduced pulmonary volume.
Restrictive ventilatory impairment.
Progressive dyspnea.
Respiratory distress.
Serial imaging can be valuable when enlargement is suspected.
10.3 Infection and fistula formation
Chronic collections may become infected.
Potential consequences include:
Tuberculous empyema.
Bacterial empyema.
Bronchopleural fistula.
Pleurocutaneous fistula.
Chest wall abscess.
These complications may require antimicrobial treatment and surgical management.
10.4 Tuberculosis reactivation
Late reactivation of tuberculosis is an important but uncommon reported complication.
Fahy and colleagues described reactivation 54 years after the original oil instillation.
This observation reinforces the importance of investigating new symptoms rather than assuming that every abnormality represents an inactive historical lesion.
10.5 Malignancy and other unusual complications
Rare reports have described unusual long-term complications involving adjacent thoracic structures.
Freedman and colleagues reported fatty infiltration of osseous structures associated with oleothorax, resulting in pathologic vertebral fracture and potential spinal complications.
A new soft-tissue component, destructive bone lesion, or progressive chest wall abnormality should therefore prompt further investigation.
10.6 Overall prognosis
For an asymptomatic patient with a stable lesion and no evidence of infection or malignancy, the prognosis may be favorable.
However, the condition should not be regarded as universally harmless.
The best long-term strategy is individualized clinical surveillance, appropriate cross-sectional imaging when indicated, and prompt evaluation of new symptoms.
11. Case-Based Clinical and Radiological Discussion
Case 1: Incidental oleothorax in an 86-year-old woman
An 86-year-old woman with hypertension and a history of pulmonary tuberculosis treatment during the 1950s presented with burning chest and upper abdominal pain.
She had no respiratory symptoms.
After acute coronary syndrome was excluded, her symptoms improved with treatment directed at gastroesophageal reflux.
Chest posteroanterior radiography demonstrated a dense opacity in the left upper hemithorax.
The differential diagnosis included chronic calcified empyema, hemothorax, and oleothorax.
Her remote tuberculosis treatment history strongly favored oleothorax.
The most important point is that the thoracic finding was incidental and was not established as the cause of her presenting pain.
This case demonstrates how an obsolete tuberculosis treatment can produce an unexpected radiographic finding many decades later.
Case 2: Large calcified oleothorax in an 83-year-old woman
The second patient was an 83-year-old woman with a history of pulmonary tuberculosis at 15 years of age.
She presented with a seven-day history of productive cough, dark sputum, exertional dyspnea, and left-sided pleuritic chest pain.
Her clinical history also included hypertension and a previous ischemic stroke.
Chest radiography revealed a large oval-shaped calcified mass in the left upper thorax.
A separate linear calcified pleural abnormality was also identified along the right lateral chest wall.
The imaging findings were compatible with chronic oleothorax and residual pleural calcification.
The patient had not previously been aware of the thoracic abnormality.
Her acute clinical presentation was attributed to community-acquired bronchitis associated with newly recognized acute heart failure, rather than automatically attributing all symptoms to the oleothorax.
This distinction is essential in clinical reasoning.
An old radiographic abnormality may coexist with an unrelated acute disease.
11.1 Comparison of the two cases
| Feature | Case 1 | Case 2 |
|---|---|---|
| Age | 86 years | 83 years |
| TB history | Treatment in the 1950s | TB at age 15 |
| Main presentation | Chest and upper abdominal pain | Cough, dyspnea, pleuritic pain |
| Respiratory symptoms | Absent | Present |
| Imaging | Chest PA | PA and lateral chest radiographs |
| Main finding | Left upper thoracic opacity | Large calcified left apical mass |
| Additional finding | Not specified | Separate right pleural calcification |
| Clinical interpretation | Incidental oleothorax | Historical oleothorax with concurrent acute illness |
The cases emphasize that oleothorax can have different clinical presentations, ranging from an incidental radiographic finding to a lesion discovered during evaluation of respiratory symptoms.
12. Practical Imaging Pearls for Radiologists
The following observations are particularly useful when interpreting an unusual thoracic mass in an elderly patient.
Pearl 1: Always ask about historical tuberculosis treatment.
A remote history of pulmonary tuberculosis may be more diagnostically valuable than the patient's current respiratory symptoms.
Pearl 2: Recognize the pleural-based configuration.
A large, well-defined, oval or lenticular thoracic opacity with peripheral calcification should raise suspicion for an organized pleural process.
Pearl 3: Do not confuse oleothorax with lipoid pneumonia.
Oleothorax is an intrapleural oil collection. Lipoid pneumonia is a pulmonary parenchymal inflammatory condition caused by lipid accumulation within the lung.
Pearl 4: Use CT to characterize uncertain lesions.
Negative attenuation within an encapsulated pleural collection can provide an important clue to the presence of residual oil.
Pearl 5: Look for associated pleural and extrapleural abnormalities.
Separate calcified pleural plaques, rib resections, chest wall changes, and previous surgical findings may provide evidence of historical treatment.
Pearl 6: Evaluate interval change.
An enlarging lesion requires further investigation, even when the original diagnosis of oleothorax is well established.
Pearl 7: Do not automatically attribute current symptoms to an old lesion.
An unrelated respiratory, cardiovascular, gastrointestinal, or musculoskeletal condition may explain the patient's acute presentation.
13. Knowledge Assessment: Three Clinical Questions
The following questions are designed for radiologists, pulmonologists, medical students, residents, and readers interested in medical imaging.
Question 1: Recognition of Oleothorax
An 86-year-old woman with a history of pulmonary tuberculosis treatment during the 1950s undergoes chest radiography for chest discomfort. She has no respiratory symptoms. The radiograph demonstrates a large, well-defined opacity in the left upper hemithorax.
Which diagnosis should be considered most likely?
A. Chronic hemothorax
B. Oleothorax
C. Primary lung cancer
D. Asbestosis
E. Acute pulmonary embolism
Correct answer: B. Oleothorax
Explanation:
Oleothorax should be considered when an elderly patient with a remote history of tuberculosis treatment demonstrates a characteristic pleural-based thoracic opacity.
Before effective antituberculous chemotherapy became widely available, oil was introduced into the pleural cavity to produce mechanical collapse of the affected lung.
The oil was generally intended to be removed after the treatment period. However, some patients were lost to follow-up, resulting in persistent collections that may remain visible decades later.
The absence of respiratory symptoms does not exclude oleothorax.
Question 2: CT Characteristics
Which CT finding is most suggestive of chronic oleothorax?
A. A spiculated pulmonary nodule with soft-tissue attenuation
B. Diffuse bilateral ground-glass opacities
C. An encapsulated pleural collection containing negative-attenuation lipid material
D. Multiple random pulmonary nodules
E. Diffuse interlobular septal thickening
Correct answer: C. An encapsulated pleural collection containing negative-attenuation lipid material
Explanation:
A characteristic CT feature of oleothorax is an encapsulated pleural collection containing lipid material.
The lipid component may demonstrate negative attenuation, commonly reported in the approximate range of −30 to −150 HU.
Depending on chronic organization, the collection may also demonstrate internal heterogeneity, peripheral calcification, and associated pleural thickening.
CT helps distinguish oleothorax from solid pulmonary neoplasms, chronic empyema, and other pleural abnormalities.
Question 3: Management of an Asymptomatic Patient
An 82-year-old patient is found to have a large calcified pleural collection compatible with oleothorax. The patient has no respiratory symptoms, no fever, and no imaging evidence of infection or progressive enlargement.
What is the most appropriate initial management?
A. Immediate thoracotomy in every case
B. Routine long-term antibiotic treatment
C. Immediate antituberculous chemotherapy
D. Individualized clinical observation and imaging follow-up
E. Immediate pleural biopsy regardless of imaging characteristics
Correct answer: D. Individualized clinical observation and imaging follow-up
Explanation:
An asymptomatic, stable oleothorax without evidence of infection or malignancy does not automatically require invasive treatment.
Clinical observation and individualized imaging follow-up may be appropriate.
Intervention should be considered when clinically significant complications develop, including progressive enlargement, respiratory compromise, infection, fistula formation, or suspected malignancy.
Treatment decisions should be individualized according to the patient's symptoms, overall health, imaging findings, and procedural risks.
14. Conclusion
Oleothorax is a rare but clinically significant historical consequence of collapse therapy for pulmonary tuberculosis.
Although the procedure was largely abandoned following the development of effective antituberculous chemotherapy, residual intrapleural oil collections may persist for many decades.
On chest radiography, oleothorax may appear as a large, well-defined, oval or lenticular thoracic opacity, frequently with peripheral calcification. CT provides additional information regarding the collection's composition, pleural location, degree of encapsulation, and relationship to adjacent structures.
The most important differential diagnoses include chronic calcified empyema, organized hemothorax, pleural malignancy, and other calcified thoracic masses.
A detailed history of previous tuberculosis treatment is essential. In selected patients, recognition of a characteristic imaging pattern can prevent unnecessary invasive procedures.
Nevertheless, long-term complications such as progressive enlargement, respiratory impairment, infection, fistula formation, and tuberculosis reactivation must be considered.
The two elderly patients presented in this article illustrate an important lesson for contemporary medicine: historical medical procedures can leave permanent anatomical changes that remain clinically relevant decades after treatment.
For radiologists and clinicians, recognizing oleothorax is therefore not simply an exercise in medical history. It is an essential component of accurate thoracic imaging interpretation, appropriate differential diagnosis, and patient-centered clinical management.
15. Medical Disclaimer
This article is intended for medical education and professional information. It does not replace individualized clinical assessment, radiological interpretation, or specialist consultation.
Management of suspected oleothorax should be based on the patient's clinical condition, imaging findings, microbiological investigations when indicated, and assessment by appropriately qualified healthcare professionals.
The educational cases described here should not be interpreted as providing a universal treatment recommendation.
References
[1] R. H. Browning, E. S. Ray, and L. Rotenberg, “Oleothorax: A reevaluation, with a final report of 101 cases,” American Review of Tuberculosis, vol. 54, no. 2, pp. 122–127, 1946. doi: 10.1164/art.1946.54.2.122.
[2] M. B. Hermel and J. Gershon-Cohen, “Healing mechanisms of tuberculous cavities,” Radiology, vol. 63, no. 4, pp. 544–549, 1954. doi: 10.1148/63.4.544.
[3] M. D. Iseman, “Tuberculosis therapy: Past, present and future,” European Respiratory Journal, vol. 20, suppl. 36, pp. 87s–94s, 2002. doi: 10.1183/09031936.02.00309102.
[4] T. M. Daniel, “The history of tuberculosis,” Respiratory Medicine, vol. 100, no. 11, pp. 1862–1870, 2006. doi: 10.1016/j.rmed.2006.08.006.
[5] L. Hutton, “Oleothorax: Expanding pleural lesion,” AJR American Journal of Roentgenology, vol. 142, no. 6, pp. 1107–1110, 1984. doi: 10.2214/ajr.142.6.1107.
[6] D. M. Mullin, B. A. Rodan, W. J. Bean, T. M. Gocke, and T. S. Feng, “Computed tomography of oleothorax,” Journal of Computerized Tomography, vol. 10, no. 2, pp. 197–199, 1986. doi: 10.1016/0149-936X(86)90076-7.
[7] B. P. Deboisblanc, W. C. Burch, Jr., H. A. Buechner, and E. F. Haponik, “Computed tomographic appearance of an oleothorax,” Thorax, vol. 43, no. 7, pp. 572–573, 1988. doi: 10.1136/thx.43.7.572.
[8] B. J. Freedman, D. M. McCarthy, F. Feldman, and N. Feirt, “Fatty infiltration of osseous structures: A long-term complication of oleothorax—case report,” Radiology, vol. 210, no. 2, pp. 515–517, 1999. doi: 10.1148/radiology.210.2.r99fe42515.
[9] R. J. Fahy, J. Morales, and M. King, “Late reactivation of tuberculosis in an oleothorax,” Journal of Thoracic Imaging, vol. 19, no. 1, pp. 35–37, 2004. doi: 10.1097/00005382-200401000-00006.
[10] B. Hochhegger, G. Zanetti, and E. Marchiori, “An uncommon chest mass: Oleothorax,” Jornal Brasileiro de Pneumologia, vol. 42, no. 5, p. 391, 2016. doi: 10.1590/S1806-37562015000000217.
[11] M. Pimentel Nunes, I. Branco Carvalho, I. Araújo, and R. Almeida, “Oleothorax: A historic chest radiograph finding,” Cureus, vol. 15, no. 1, Art. no. e33305, 2023. doi: 10.7759/cureus.33305.
[12] K. R. Flores et al., “Oleothorax: An ultrasound sign of an old practice,” Respiration, vol. 103, no. 6, pp. 353–358, 2024. doi: 10.1159/000538276.
Comments
Post a Comment